Suppr超能文献

特殊调节性T细胞综述:换个名字的玫瑰:从抑制性T细胞到调节性T细胞,从认可到过度热情。

Special regulatory T-cell review: A rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm.

作者信息

Germain Ronald N

机构信息

Lymphocyte Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Immunology. 2008 Jan;123(1):20-7. doi: 10.1111/j.1365-2567.2007.02779.x.

Abstract

In the early 1970s a spate of papers by research groups around the world provided evidence for a negative regulatory role of thymus-derived lymphocytes (T cells). In 1971, Gershon and Kondo published a seminal paper in Immunology entitled 'Infectious Immunological Tolerance' indicating that such negative regulation could be a dominant effect that prevented otherwise 'helpful' T cells from mediating their function. Over the next decade, suppressor T cells, as these negative regulatory cells became known, were intensively investigated and a complex set of interacting cells and soluble factors were described as mediators in this process of immune regulation. In the early 1980s, however, biochemical and molecular experiments raised questions about the interpretation of the earlier studies, and within a few years, the term 'suppressor T cell' had all but disappeared from prominence and research on this phenomenon was held in poor esteem. While this was happening, new studies appeared suggesting that a subset of T cells played a critical role in preventing autoimmunity. These T cells, eventually dubbed 'regulatory T cells', have become a major focus of modern cellular immunological investigation, with a predominance that perhaps eclipses even that seen in the earlier period of suppressor T cell ascendancy. This brief review summarizes the rise and fall of 'suppressorology' and the possibility that Tregs are a modern rediscovery of suppressor T cells made convincing by more robust models for their study and better reagents for their identification and analysis.

摘要

20世纪70年代初,世界各地研究小组发表的一系列论文为胸腺来源的淋巴细胞(T细胞)的负调节作用提供了证据。1971年,格申(Gershon)和近藤(Kondo)在《免疫学》杂志上发表了一篇具有开创性的论文,题为《传染性免疫耐受》,表明这种负调节可能是一种主导效应,阻止了原本“有益”的T细胞发挥其功能。在接下来的十年里,这些负调节细胞被称为抑制性T细胞,受到了深入研究,一组复杂的相互作用细胞和可溶性因子被描述为免疫调节过程中的介质。然而,在20世纪80年代初,生化和分子实验对早期研究的解释提出了质疑,几年内,“抑制性T细胞”这个术语几乎不再突出,对这一现象的研究也不受重视。与此同时,新的研究表明,T细胞的一个亚群在预防自身免疫方面起着关键作用。这些T细胞最终被称为“调节性T细胞”,已成为现代细胞免疫学研究的主要焦点,其受关注程度甚至可能超过了早期抑制性T细胞占主导地位的时期。这篇简短的综述总结了“抑制性T细胞学说”的兴衰,以及调节性T细胞可能是抑制性T细胞的现代重新发现,这一观点因更强大的研究模型和更好的鉴定与分析试剂而更具说服力。

相似文献

2
特殊调节性T细胞综述:抑制细胞受到调控但未被抑制。
Immunology. 2008 Jan;123(1):28-32. doi: 10.1111/j.1365-2567.2007.02773.x.
3
调节性T细胞——简史与展望
Eur J Immunol. 2007 Nov;37 Suppl 1:S116-23. doi: 10.1002/eji.200737593.
4
调节性T细胞——抑制性T细胞的复兴。
Ann Med. 2007;39(5):322-34. doi: 10.1080/07853890701379700.
5
五十年的免疫耐受
Folia Biol (Praha). 1998;44(6):189-92.
6
特殊调节性T细胞综述:免疫反应的调节——审视T细胞的作用。
Immunology. 2008 Jan;123(1):13-6. doi: 10.1111/j.1365-2567.2007.02775.x.
7
CD4+CD25+调节性T细胞是如何控制自身免疫的?
Curr Opin Immunol. 2005 Dec;17(6):638-42. doi: 10.1016/j.coi.2005.09.002. Epub 2005 Oct 4.
8
T细胞介导的免疫抑制作用的恢复
J Immunol. 2011 Apr 1;186(7):3805-7. doi: 10.4049/jimmunol.1100364.
9
调节性 T 细胞:免疫系统的抑制性分支。
Autoimmun Rev. 2010 Dec;10(2):112-5. doi: 10.1016/j.autrev.2010.08.013. Epub 2010 Aug 31.
10
调节性T细胞:它们如何在免疫舞台上找到自己的立足之地?
Semin Cancer Biol. 2006 Apr;16(2):91-7. doi: 10.1016/j.semcancer.2005.11.002. Epub 2005 Dec 27.

引用本文的文献

2
调节性CD4 T细胞:免疫的永久性或临时性抑制因子
Front Immunol. 2024 Feb 7;15:1293892. doi: 10.3389/fimmu.2024.1293892. eCollection 2024.
3
增强调节性 T 细胞治疗炎症和自身免疫性疾病。
Int J Mol Sci. 2023 Apr 25;24(9):7797. doi: 10.3390/ijms24097797.
5
CD8 调节性 T 细胞——有待揭示的谜团。
Front Immunol. 2021 Aug 18;12:708874. doi: 10.3389/fimmu.2021.708874. eCollection 2021.
6
调节性 T 细胞在经皮免疫治疗食物过敏中的作用。
Front Immunol. 2021 Jul 8;12:660974. doi: 10.3389/fimmu.2021.660974. eCollection 2021.
7
组织调节性 T 细胞。
Immunology. 2020 Sep;161(1):4-17. doi: 10.1111/imm.13208. Epub 2020 Jun 24.
8
基因修饰调节性 T 细胞的治疗潜力:从基础到临床。
Front Immunol. 2018 Feb 16;9:303. doi: 10.3389/fimmu.2018.00303. eCollection 2018.
9
CD28与CD28⁺CD8⁺调节性T细胞:从鼠到人的研究
Front Immunol. 2017 Jan 23;8:31. doi: 10.3389/fimmu.2017.00031. eCollection 2017.

本文引用的文献

1
CD4+CD25+Foxp3+调节性T细胞诱导效应性CD4+T细胞发生细胞因子剥夺介导的凋亡。
Nat Immunol. 2007 Dec;8(12):1353-62. doi: 10.1038/ni1536. Epub 2007 Nov 4.
3
调节性T细胞、转化生长因子-β与免疫抑制
Proc Am Thorac Soc. 2007 Jul;4(3):271-6. doi: 10.1513/pats.200701-020AW.
4
FOXP3+调节性T细胞:当前争议与未来展望。
Eur J Immunol. 2006 Nov;36(11):2832-6. doi: 10.1002/eji.200636459.
5
感染性耐受与移植组织的长期接受
Immunol Rev. 2006 Aug;212:301-13. doi: 10.1111/j.0105-2896.2006.00406.x.
6
调节性T细胞可逆性抑制细胞毒性T细胞功能,且不依赖效应细胞分化。
Immunity. 2006 Jul;25(1):129-41. doi: 10.1016/j.immuni.2006.04.015.
7
致病性效应T辅助细胞17(TH17)和调节性T细胞产生的相互发育途径。
Nature. 2006 May 11;441(7090):235-8. doi: 10.1038/nature04753. Epub 2006 Apr 30.
8
正常和FOXP3突变型人类T细胞的单细胞分析:无调节性T细胞发育的FOXP3表达
Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6659-64. doi: 10.1073/pnas.0509484103. Epub 2006 Apr 14.
9
10
免疫自我耐受和自身免疫性疾病中的调节性T细胞。
Int Rev Immunol. 2005 May-Aug;24(3-4):211-26. doi: 10.1080/08830180590934976.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验